LA HEALTHCARE

NIH awards Children’s Hospital L.A. $1.7M to Study Preemies

The National Institutes of Health has awarded Children’s Hospital Los Angeles $1.7 million to research the brains of premature babies.

Tease photo

Feds Give Kite Pharma’s Cancer Treatment the Green Light

The U.S. Food and Drug Administration has approved a cancer therapy developed by Kite Pharma that involves rejiggering a patient’s immune cells to kill cancer.

Tease photo

One in Four L.A. Hospital Patients Readmitted Within 30 days

A quarter of patients admitted to Los Angeles County hospitals are readmitted within 30 days, the highest rate in the state for any county with more than one hospital, according to a recent study.

Layoffs as Hollywood Nursing Home, Subject of Complaints, to Close

An East Hollywood nursing home that has been the subject of a flood of complaints for patient abuse and neglect will close this week, with nearly 130 workers to lose their jobs.

Eos Biosciences Wins Patent for Cancer Drug Delivery System

Eos Biosciences, a Los Angeles nanomedicines company affiliated with Cedars-Sinai Medical Center, has obtained a patent for a drug delivery platform aimed toward breast cancer.

L.A. Oncologists Develop Safe Method to Diagnose Children’s Eye Cancer

Two leading Los Angeles medical institutes have developed a liquid biopsy for a cancer of the retina that can blind or kill children younger than 5 years old, researchers announced Monday.

Tease photo

CytRx Licenses Cancer Drug to NantCell; Asks Shareholders for Reverse Stock Split

Brentwood-based CytRx Corp. will team up with Patrick Soon-Shiong’s NantCell Inc. of Culver City to test a late-stage cancer drug, CytRx announced Thursday. The company also asked investors Tuesday to approve a one-for-six reverse stock split to continue the company’s listing on the Nasdaq exchange, according to Securities and Exchange Commission filings.

Tease photo

Molina Healthcare Appoints New Chief Executive

Molina Healthcare Inc. named Joseph M. Zubretsky chief executive Tuesday after a summer that included a layoff announcement and c-suite shakeup.

Tease photo

Children’s Hospital L.A. Awarded $9M to Study ‘Bubble Boy’ Syndrome

Children’s Hospital Los Angeles has received a nearly $9 million federal grant to research a new treatment for infants born with severe combined immunodeficiency, commonly known as “bubble boy” syndrome.

Tease photo

Sean Parker's Institute Backs Cancer Firm ImaginAb's $8M Funding Round

ImaginAb Inc., an Inglewood immune-oncology imaging company, has teamed up with a San Francisco cancer institute to launch human clinical trials after receiving $8 million in new funding.

Tease photo

City of Hope Wins $13 Million Grant to Fight Aggressive Brain Cancer

Researchers at City of Hope National Medical Center have won a $13 million grant to fund a clinical trial employing CAR-T cell immunotherapy to kill brain cancer.

Tease photo

Ritter Pharma Raises $23 million to Test Lactose Intolerance Treatment

Ritter Pharmaceuticals Inc., a Century City biotech company that develops therapies for gastrointestinal diseases, raised $23 million to fund a Phase 3 clinical trial for its lactose intolerance treatment.

Los Angeles Pet Device Firm Draws $3.7 Million Investment

Petnet Inc., a privately held Los Angeles company that sells automatic pet feeders for cats and dogs, has received a $3.75 million cash infusion, according to an SEC filing.

L.A. Biotech’s Summer Sizzle

HEALTH CARE: Approvals, big deal boost sector’s local profile.

L.A.’s biotech sector shows signs of life with drug approvals and an $11.9 billion deal for Kite.

Tease photo

Ahmanson/UCLA Adult Congenital Heart Disease Center Earns Accreditation

A congenital heart disease center run by UCLA has just become the first nationally accredited center of its kind in Los Angeles, and the 11th in the U.S.